Comprehensive characterization of T cell subtypes in lung adenocarcinoma: Prognostic, predictive, and therapeutic implications
We developed a powerful prognostic signature in LUAD that accurately predicts clinical outcomes and can guide immunotherapy and chemotherapy responses.
Authors
- Teresa Song (ORCID: https://orcid.org/0000-0002-1507-9933)
- Haiyong Zhu (ORCID: https://orcid.org/0000-0002-7202-092X)
- Lele Deng
- Hao Sun (ORCID: https://orcid.org/0000-0002-3670-2886)
- Shujun Li (ORCID: https://orcid.org/0000-0001-5959-3160)
- Ce Liang
- Shiquan Liu (ORCID: https://orcid.org/0000-0002-3552-8732)
- Fangchao Zhao (ORCID: https://orcid.org/0000-0002-2552-2249)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- Chengde Medical University (CN)
- Xinqiao Hospital (CN)
- Universidad Autónoma de Madrid (ES)
- Air Force Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1016/j.tranon.2025.102332
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05